CIMAvax-EGF in different maintenance schemes |
12/05/2021 |
CIM |
CIGB-128 administration to patients with surgically-treated keloids. |
2010-12-24 |
CIGB |
CIGB 2020 in contacts and SARS-CoV-2 infection suspects |
13/04/2020 |
CIGB |
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults |
18/03/2021 |
CIM |
BIOMODULINA T in a long-lived population at high risk of COVID-19 infection |
19/09/2020 |
BIOCEN |
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study |
21/12/2020 |
BIOCEN |
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III |
14/08/2017 |
BIOCEN |
AntiCEA M3-I |
2010-12-20 |
CIGB |
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer. |
10/07/2018 |
ROCHE |
99mTc-marked 14F7 MaB in metastatic breast, phase II |
2008-12-27 |
CIM |
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II |
2010-12-17 |
CIM |
1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma |
01/09/2016 |
CIM |